Coegin pharma

Picture of abstract light forming different shapes
Visit company website

Coegin Pharma AS develops a new therapeutic approach to modulate cPLA levels in patients with certain forms of cancer and Chronic Kidney Disease.

Coegin Pharma AS develops a new therapeutic approach to modulate cPLA levels in patients with certain forms of cancer and Chronic Kidney Disease.

Latest news about Coegin pharma

  • Mon Jan 02 2023

    Coegin Pharma raises 25 mSEK

    Coegin Pharma AB (COEGIN:Nordic GM) raises 25,3 mSEK through combined rights issue and directed new

    Read full article
  • Fri Mar 04 2022

    Coegin Pharma merges with Follicum

    Coegin Pharma has announced successfully completing the merger acquisition of Lund-based diabetes co

    Read full article